Increasing clinical impact and microbiological difficulties in diagnosing coagulase-negative staphylococci in infective endocarditis – a review starting from a series of cases

References

• Leone S, Ravasio V, Durante-Mangoni E, et al. Epidemiology, characteristics, and outcome of infective endocarditis in Italy: the Italian study on endocarditis. Infection. 2012;40(5):527–535.
   PubMed Web of Science ®Google Scholar
• Baddour LM, Wilson WR, Bayer AS, et al. American Heart Association Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and Stroke Council Infective Endocarditis in Adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association. Circulation. 2015;132(15):1435–1486.
   PubMed Web of Science ®Google Scholar
• Castillo JC, Anguita MP, Torres F, et al. Risk factors associated with endocarditis without underlying heart disease. Rev. Española Cardiol. 2002;55(3):304–307.
   PubMed Web of Science ®Google Scholar
• Habib G, Lancellotti P, Antunes MJ, et al. ESC guidelines for the management of infective endocarditis. Eur Heart J. 2015;36(44):3075–3128.
   PubMed Web of Science ®Google Scholar
• Holland TL, Baddour LM, Bayer AS, et al. Infective endocarditis. Nat Rev Dis Primers. 2016;2:16059.
   PubMed Web of Science ®Google Scholar
• Dayer MJ, Jones S, Prendergast B, et al. Incidence of infective endocarditis in England, 2000-13: a secular trend, interrupted time-series analysis. Lancet. 2015;385(9974):1219–1228.
   PubMed Web of Science ®Google Scholar
• Van den Brink FS, Swaans MJ, Hoogendijk MG, et al. Increased incidence of infective endocarditis after the 2009 European Society of Cardiology guideline update: a nationwide study in The Netherlands. Eur Hear J Qual Care Clin Outcomes. 2017;3(2):141–147.
   PubMed Web of Science ®Google Scholar
• Hoen B, Chirouze C, Cabell CH, et al. International collaboration on endocarditis study group emergence of endocarditis due to group D streptococci: findings derived from the merged database of the international collaboration on endocarditis. Eur J Clin Microbiol Infect Dis. 2005;24(1):12–16.
   PubMed Web of Science ®Google Scholar
• Al-Tamtami N, Al-Lawati J, Al-Abri S. Native valve endocarditis caused by coagulase negative staphylococci; an appeal to start outpatient antimicrobial therapy: an unusual case report. Oman Med J. 2011;26(4):269–270.
   PubMedGoogle Scholar
• Chu V, Woods C, Miro J, et al. International collaboration on ENDOCARDITIS-PROSPECTIVE cohort study group emergence of coagulase-negative staphylococci as a cause of native valve endocarditis. Clin Infect Dis. 2008;46(2):232–242.
   PubMed Web of Science ®Google Scholar
• Michels R, Last K, Becker SL, et al. Update on coagulase-negative staphylococci-what the clinician should know. Microorganisms. 2021;9(4):830.
   PubMed Web of Science ®Google Scholar
• Petti CA, Simmon KE, Miro JM, et al. International collaboration on endocarditis-microbiology investigators genotypic diversity of coagulase-negative staphylococci causing endocarditis: a global perspective. J Clin Microbiol. 2008;46(5):1780–1784.
   PubMed Web of Science ®Google Scholar
• Noshak MA, Rezaee MA, Hasani A, et al. The role of the coagulase-negative staphylococci (CoNS) in infective endocarditis; a narrative review from 2000 to 2020. Curr Pharm Biotechnol. 2020;21(12):1140–1153.
   PubMed Web of Science ®Google Scholar
• Becker K, Heilmann C, Peters G. Coagulase-negative staphylococci. Clin Microbiol Rev. 2014;27(4):870–926.
   PubMed Web of Science ®Google Scholar
• Haro J, Lomas J, Plata A, et al. Left-sided native valve endocarditis by coagulase-negative staphylococci: an emerging disease. Enferm. Infecc. Microbiol. Clin. 2008;26:263–268.
   PubMed Web of Science ®Google Scholar
• Etienne J, Eykyn SJ. Increase in native valve endocarditis caused by coagulase negative staphylococci: an Anglo-French clinical and microbiological study. Br Heart J. 1990;64(6):381–384.
   PubMedGoogle Scholar
• Chu VH, Cabell CH, Abrutyn E, et al. Group TIC on EMDS native valve endocarditis due to coagulase-negative staphylococci: report of 99 episodes from the international collaboration on endocarditis merged database. Clin Infect Dis. 2004;39(10):1527–1530.
   PubMed Web of Science ®Google Scholar
• Williams ML, Doyle MP, McNamara N, et al. Epidemiology of infective endocarditis before versus after change of international guidelines: a systematic review. Ther Adv Cardiovasc Dis. 2021;15:17539447211002687.
   Google Scholar
• Strom BL, Abrutyn E, Berlin JA, et al. Dental and cardiac risk factors for infective endocarditis: a population-based, case-control study. Ann Intern Med. 1998;129(10):761–769.
   PubMed Web of Science ®Google Scholar
• Katan O, Michelena HI, Avierinos J-F, et al. Incidence and predictors of infective endocarditis in mitral valve prolapse. Mayo Clin. Proc. 2016;91(3):336–342.
   PubMed Web of Science ®Google Scholar
• CDC Bloodstream Infection Event (Central Line-Associated Bloodstream Infection and Non-Central Line Associated Bloodstream Infection). 2021. [cited 2022 Jul 20]. Available from https://www.cdc.gov/nhsn/pdfs/pscmanual/4psc_clabscurrent.pdf.
   Google Scholar
• Elzi L, Babouee B, Vögeli N, et al. How to discriminate contamination from bloodstream infection due to coagulase-negative staphylococci: a prospective study with 654 patients. Clin Microbiol Infect. 2012;18(9):E355–E361.
   PubMed Web of Science ®Google Scholar
• Osaki S, Kikuchi K, Moritoki Y, et al. Distinguishing coagulase-negative Staphylococcus bacteremia from contamination using blood-culture positive bottle detection pattern and time to positivity. J. Infect. Chemother. 2020;26(7):672–675.
   PubMed Web of Science ®Google Scholar
• Lu B, Shi L, Zhu F, et al. Clinical utility of the time-to-positivity/procalcitonin ratio to predict bloodstream infection due to coagulase-negative staphylococci. Lab Med. 2013;44(4):313–318.
   Web of Science ®Google Scholar
• Argemi X, Riegel P, Lavigne T, et al. Implementation of matrix-assisted laser desorption ionization–time of flight mass spectrometry in routine clinical laboratories improves identification of coagulase-negative staphylococci and reveals the pathogenic role of Staphylococcus lugdunensis. J Clin Microbiol. 2015;53(7):2030–2036.
   PubMed Web of Science ®Google Scholar
• VanAken SM, Newton D, VanEpps JS. Improved diagnostic prediction of the pathogenicity of bloodstream isolates of Staphylococcus epidermidis. PLoS One. 2021;16(3):e0241457.
   PubMed Web of Science ®Google Scholar
• Karchmer AW, Archer GL, Dismukes WE. Staphylococcus epidermidis causing prosthetic valve endocarditis: microbiologic and clinical observations as guides to therapy. Ann Intern Med. 1983;98(4):447–455.
   PubMed Web of Science ®Google Scholar
• García de la Mària C, Cervera C, Pericàs JM, et al. Hospital clinic endocarditis study group HCES epidemiology and prognosis of coagulase-negative staphylococcal endocarditis: impact of vancomycin minimum inhibitory concentration. PLoS One. 2015;10(5):e0125818.
   PubMed Web of Science ®Google Scholar
• Power N, Calisti G, Price F, et al. Staphylococcus simulans endocarditis of native aortic and mitral valves. Case report and literature review. Clin. Infect. Pract. 2020;7-8:100044.
   Google Scholar
• Kini GD, Patel K, Parris AR, et al. An unusual presentation of endocarditis caused by Staphylococcus warneri. Open Microbiol J. 2010;4:103–105.
   PubMedGoogle Scholar
• Gander RM, Byrd L, DeCrescenzo M, et al. Impact of blood cultures drawn by phlebotomy on contamination rates and health care costs in a hospital emergency department. J Clin Microbiol. 2009;47(4):1021–1024.
   PubMed Web of Science ®Google Scholar
• Alahmadi YM, Aldeyab MA, McElnay JC, et al. Clinical and economic impact of contaminated blood cultures within the hospital setting. J. Hosp. Infect. 2011;77(3):233–236.
   PubMed Web of Science ®Google Scholar
• Vieira MLC, Grinberg M, Pomerantzeff PMA, et al. Repeated echocardiographic examinations of patients with suspected infective endocarditis. Heart. 2004;90(9):1020–1024.
   PubMed Web of Science ®Google Scholar
• Philip M, Tessonier L, Mancini J, et al. Comparison between ESC and duke criteria for the diagnosis of prosthetic valve infective endocarditis. JACC Cardiovasc Imaging. 2020;13(12):2605–2615.
   PubMed Web of Science ®Google Scholar
• Widerström M. Commentary: significance of Staphylococcus epidermidis in health care-associated infections, from contaminant to clinically relevant pathogen: this is a wake-up call! J Clin Microbiol. 2016;54(7):1679–1681.
   PubMed Web of Science ®Google Scholar
• Wang S, Liu C, Tseng H, et al. Staphylococcus capitis bacteremia of very low birth weight premature infants at neonatal intensive care units: clinical significance and antimicrobial susceptibility. J Microbiol Immunol Infect. 1999;32(1):26–32. (accessed July 25, 2020).
   PubMedGoogle Scholar
• Barbier F, Ruppé E, Hernandez D, et al. Methicillin‐resistant coagulase‐negative staphylococci in the community: high homology of SCCmec IVa between Staphylococcus epidermidis and major clones of methicillin‐resistant Staphylococcus aureus. J Infect Dis. 2010;202(2):270–281.
   PubMed Web of Science ®Google Scholar
• Jamaluddin TZMT, Kuwahara-Arai K, Hisata K, et al. Extreme genetic diversity of methicillin-resistant Staphylococcus epidermidis strains disseminated among healthy Japanese children. J Clin Microbiol. 2008;46(11):3778–3783.
   PubMed Web of Science ®Google Scholar
• Marincola G, Liong O, Schoen C, et al. Antimicrobial resistance profiles of coagulase-negative staphylococci in community-based healthy individuals in Germany. Front Public Heal. 2021;9:684456.
   PubMed Web of Science ®Google Scholar
• Al-Tamimi M, Abu-Raideh J, Himsawi N, et al. Methicillin and vancomycin resistance in coagulase-negative staphylococci isolated from the nostrils of hospitalized patients. J Infect Dev Ctries. 2020;14(1):28–35.
   PubMed Web of Science ®Google Scholar
• Tewhey R, Gu B, Kelesidis T, et al. Mechanisms of linezolid resistance among coagulase-negative staphylococci determined by whole-genome sequencing. MBio. 2014;5(3):e00894–14.
   PubMed Web of Science ®Google Scholar
• Rosenthal S, Decano AG, Bandali A, et al. Oritavancin (orbactiv): a new-generation lipoglycopeptide for the treatment of acute bacterial skin and skin structure infections. P T. 2018;43(3):143–179.
   PubMedGoogle Scholar
• Chen AY, Zervos MJ, Vazquez JA. Dalbavancin: a novel antimicrobial. Int J Clin Pract. 2007;61(5):853–863.
   PubMed Web of Science ®Google Scholar
• Chu VH. Coagulase-negative staphylococci and endocarditis: reappraisal in the 21st century. Enferm Infecc Microbiol Clin. 2008;26(5):261–262.
   PubMed Web of Science ®Google Scholar
• Mayo M, Hutton A, Okpokpo E. Staphylococcus epidermidis native valve endocarditis. Crit. Care Med. 2022;50(1):170–170.
   Web of Science ®Google Scholar